FDA Investigator Dien N Nguyen

Dien N Nguyen has conducted inspections on 43 sites in 3 countries as of 12 Feb 2018. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
43
Last Inspection Date:
12 Feb 2018
Investigator Role:
FDA Investigator
Redica ID:
100005340
Countries of Inspections:
United States of America, Slovakia, Italy
FDA Investigators that have inspected at least one site in common with Dien N Nguyen:
Adetutu M Gidado, Alan R Condon, Alice C Silva, Alice Canty, Amber G Wardwell, Amy C Jordan, Amy N Chen, Andrew M Barlow, Anthony C Warchut, Arie C Menachem, Armen H Youssoufian, Azza Talaat, Betsy C Galliher, Brandy L Couillard, Brenna L Macdowell, Byungja E Marciante, Calvin B Koerner, Christine M Whitby, CSO, Christopher Janik, Chunsheng Cai, PhD, Constance Desimone, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, Diane C Thibodeau, Dolores Harper, Dominic R Frasca, Donald C Obenhuber, PhD, Donald L Lech, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Eduardo L Rodriguez, Edward J Janik, Eric C Schmitt, Frank P Hurst, Gabrielle J Swain, Garry H Stewart, Gary J Hagan, Hang N Guo, Jacek Cieslak, PhD, Janete F Guardia, Jason A Rossi, Jeffrey J Thibodeau, John A Sciacchitano, John J Thibodeau, John P Mistler, John S Hartford, Johnna L Bleem, Jonah S Ufferfilge, Jonathan G Matrisciano, Jose A Torres, José E Meléndez, Jose R Hernandez, Julie D Bringger, Justine M Corson, Karen A Briggs, Kenneth H Williams, Kent A Conforti, Kimberly M White, Laurie B Frazier, LCDR Debra Emerson, Lei Zhang, PhD, Leiyun Boone, PhD, Linda L Green, LT Colin E Tack, BSE, Margaret E Walsh, Margaret M Sands, Maria Joselopez Barragan, PhD, Mark R Mcclain, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew C Watson, Maura Rooney, Maya M Davis, Megan A Haggerty, Michael G Mayfield, Michael P Anthony, Michael Serrano, Michael Shanks, MS, Michele L Obert, Michelle M Noe Varga, Michelle Rfrazier Jessen, PhD, Michelle Yclark Stuart, Mihaly S Ligmond, Mindy M Chou, Mra Mcculloughj, Nealie C Newberger, Nina Yang, Ogechi C Nna, Pamela N Agaba, Paraluman S Leonin, Paul E Stein, Paul Lihong Yeh, PhD, Peter R Lenahan, Puspa Suresh Jayasekara, Ramon E Martinez, Rapti D Madurawe, Rebecca B Welch, Reyes Candau Chacon, PhD, Richard H Penta, Richard Ledwidge (nmi), PhD, Robert D Tollefsen, Robert J Martin, Robert O'brian, Rory K Geyer, Samir C Gala, Sean R Marcsisin, Sherri N Rohlf, MD, Simone E Pitts, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen R Souza, Steven Fong, MS, PhD, Sunita Pandey, Susan M Jackson, Suzanne M Healy, Tanya R Syffrard, Terry Bridgewater, Tomika L Crafter, Tonia F Bernard, Torrance J Slayton, Tyanna N Hadley, Victoria M Daddeo, Wayne E Seifert, William Hallett, PhD, Xiaojun Yan, Yetao Jin, PhD, Ziyang Su, PhD

Dien N Nguyen's Documents

Publish Date Document Type Title
February, 2017 EIR Breckenridge Pharmaceutical, Inc. - EIR, 2017-02-21
May, 2016 FDA 483 Milbar Laboratories, Inc. - Form 483, 2016-05-17
February, 2017 FDA 483 Breckenridge Pharmaceutical, Inc. - Form 483, 2017-02-21
February, 2016 FDA 483 Anderson Holdings Inc. - Form 483, 2016-02-19
June, 2017 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2017-06-07
April, 2016 EIR Azurity Pharmaceuticals, Inc. - EIR, 2016-04-19
November, 2017 EIR Cosmo SpA - EIR, 2017-11-10
October, 2015 FDA 483 Genoa Healthcare of Connecticut, LLC - Form 483, 2015-10-05
August, 2016 FDA 483 SCS Direct Inc. - Form 483, 2016-08-23
March, 2018 FDA 483 SCA Pharmaceuticals, LLC - Form 483, 2018-03-05
June, 2017 FDA 483 Brookfield Medical/Surgical Supplies, Inc. - Form 483, 2017-06-28
June, 2017 FDA 483 Pfizer Laboratories Div Pfizer Inc - Form 483, 2017-06-07
February, 2016 FDA 483 Response Anderson Holdings Inc. - Form 483R, 2016-02-29
July, 2016 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2016-07-15
March, 2017 FDA 483 Reliant Compounded Solutions Monroe, LLC - Form 483, 2017-03-03
January, 2016 FDA 483 Arzol Chemical Company - Form 483, 2016-01-25
October, 2015 FDA 483 Genoa, a QoL Healthcare Company, LLC - Form 483, 2015-10-05
February, 2016 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2016-02-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more